Rut Porta
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
Papers in
-
- Cancer, Lipids, and Metabolism 5
- MicroRNA in disease regulation 1
-
- Lung Cancer Treatments and Mutations 7
- Medical Imaging and Pathology Studies 2
- Co-authors
- Teresa Puig (6 shared papers)Javier A. Menéndez (3 shared papers)Joan Brunet (3 shared papers)Adriana González (2 shared papers)David Paul Carbone (2 shared papers)David H. Johnson (2 shared papers)Pablo Reclusa (1 shared paper)Rafael Sirera (1 shared paper)
- Journals
- Cancer Research (2 papers)Annals of the New York Academy of Sciences (1 paper)Lung Cancer (1 paper)Critical Reviews in Oncology/Hematology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- SpainUnited StatesCanada
In The Last Decade
Rut Porta
18 papers receiving 7.3k citations
Rut Porta's Hit Papers
Peers
Comparison fields: 5 of 107
- Pulmonary and Respiratory Medicine 5.5k
- Oncology 3.2k
- Cancer Research 1.3k
- Molecular Biology 1.7k
- Pathology and Forensic Medicine 262
Countries citing papers authored by Rut Porta
This map shows the geographic impact of Rut Porta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rut Porta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rut Porta more than expected).
Fields of papers citing papers by Rut Porta
This network shows the impact of papers produced by Rut Porta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rut Porta. The network helps show where Rut Porta may publish in the future.
Co-authors
The 25 scholars most cited alongside Rut Porta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial Hit paper breakdown → | 2012 | 4725 |
| 2 | Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer Hit paper breakdown → | 2009 | 1998 |
| 3 | 2017 | 177 | |
| 4 | 2017 | 167 | |
| 5 | 2007 | 106 | |
| 6 | 2006 | 100 | |
| 7 | 2007 | 55 | |
| 8 | 2016 | 44 | |
| 9 | 2014 | 23 | |
| 10 | 2014 | 22 | |
| 11 | 2013 | 14 | |
| 12 | 2022 | 13 | |
| 13 | Neoadjuvant Chemoradiotherapy Treatment for a Classic Biphasic Pulmonary Blastoma with High PD-L1 Expression. | 2015 | 12 |
| 14 | 2009 | 8 | |
| 15 | 2021 | 8 | |
| 16 | 2010 | 7 | |
| 17 | 2012 | 7 | |
| 18 | 2015 | 2 | |
| 19 | 2010 | 0 |
About Rut Porta
Rut Porta is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Pharmacology, Oncology and Molecular Biology, having authored 19 papers that have together received 7.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Cancer, Lipids, and Metabolism (5 papers), Inflammatory mediators and NSAID effects (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Medical Imaging and Pathology Studies (2 papers), MicroRNA in disease regulation (1 paper), RNA modifications and cancer (1 paper) and Tannin, Tannase and Anticancer Activities (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.5k citations), Oncology (3.2k citations), Cancer Research (1.3k citations), Molecular Biology (1.7k citations) and Pathology and Forensic Medicine (262 citations). Rut Porta has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include Teresa Puig, Javier A. Menéndez, Joan Brunet, Adriana González, David Paul Carbone, David H. Johnson, Pablo Reclusa, Rafael Sirera, Nele Van Der Steen and Roberto Borea. Their work appears in journals such as Cancer Research, Annals of the New York Academy of Sciences, Lung Cancer, Critical Reviews in Oncology/Hematology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.